Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Fontcuberta

Showing results (11-20 of 172) with videos related to

Pageof 18
Sort By:
Sangre|January 1, 1983
[The acquired immunodeficiency syndrome. A dynamic clinico-biological situation]X Estivill, F Rueda, J Fontcuberta, et al.
Thrombosis Research|June 18, 1998
In-vitro and ex-vivo neutralizing effect of protamine sulphate on the anticoagulant activity of a new low molecular mass heparinL Falkon, M Garí, I Gich, et al.
Medicina Clinica|February 9, 1991
[Pulmonary thromboembolism during cyclosporin immunosuppressive treatment in a heart transplant patient]V Martí, C Moya, J Fontcuberta, et al.
Medicina Clinica|November 3, 1984
[Spontaneous retroperitoneal hemorrhage and anticoagulant treatment: presentation of 4 cases and review of the literature]X Estivill, P Domingo, J Fontcuberta, et al.
Angiologia|September 1, 1990
[Plasminogen depletion and incorporation in experimental venous thrombosis]J Fontcuberta, J Latorre, A Rosendo, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 1, 1992
The release of plasminogen activators (t-PA and u-PA) and plasminogen activator inhibitor (PAI-1) after venous stasisL Falkon, M Garí, M Borrell, et al.
Revista Espanola De Anestesiologia Y Reanimacion|November 1, 1992
[Indications for the use of platelets, plasma and anti-hemorrhagic drugs]J Mateo, E Muñiz-Díaz, J Fontcuberta, et al.
Medicina Clinica|May 11, 1985
[Pseudothrombocytopenia and pseudoleukocytosis]E Grau Segura, J Fontcuberta Boj, J Félez Brugués
Digestive Diseases and Sciences|July 1, 1995
Antiphospholipid antibodies in inflammatory bowel diseaseJ C Souto, M Borrell, J Fontcuberta, et al.
Hepato-Gastroenterology|May 1, 1996
Prophylaxis of thromboembolic disease with RO-11 (ROVI), during abdominal surgery. EMRO1 (Grupo Fstudio Multicintrico RO-11)E Moreno Gonzalez, J Fontcuberta, F de la Llama
Pageof 18

Showing results (11-20 of 172) with videos related to

Sort By:
Pageof 18
Sangre|January 1, 1983
[The acquired immunodeficiency syndrome. A dynamic clinico-biological situation]X Estivill, F Rueda, J Fontcuberta, et al.
Thrombosis Research|June 18, 1998
In-vitro and ex-vivo neutralizing effect of protamine sulphate on the anticoagulant activity of a new low molecular mass heparinL Falkon, M Garí, I Gich, et al.
Medicina Clinica|February 9, 1991
[Pulmonary thromboembolism during cyclosporin immunosuppressive treatment in a heart transplant patient]V Martí, C Moya, J Fontcuberta, et al.
Medicina Clinica|November 3, 1984
[Spontaneous retroperitoneal hemorrhage and anticoagulant treatment: presentation of 4 cases and review of the literature]X Estivill, P Domingo, J Fontcuberta, et al.
Angiologia|September 1, 1990
[Plasminogen depletion and incorporation in experimental venous thrombosis]J Fontcuberta, J Latorre, A Rosendo, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 1, 1992
The release of plasminogen activators (t-PA and u-PA) and plasminogen activator inhibitor (PAI-1) after venous stasisL Falkon, M Garí, M Borrell, et al.
Revista Espanola De Anestesiologia Y Reanimacion|November 1, 1992
[Indications for the use of platelets, plasma and anti-hemorrhagic drugs]J Mateo, E Muñiz-Díaz, J Fontcuberta, et al.
Medicina Clinica|May 11, 1985
[Pseudothrombocytopenia and pseudoleukocytosis]E Grau Segura, J Fontcuberta Boj, J Félez Brugués
Digestive Diseases and Sciences|July 1, 1995
Antiphospholipid antibodies in inflammatory bowel diseaseJ C Souto, M Borrell, J Fontcuberta, et al.
Hepato-Gastroenterology|May 1, 1996
Prophylaxis of thromboembolic disease with RO-11 (ROVI), during abdominal surgery. EMRO1 (Grupo Fstudio Multicintrico RO-11)E Moreno Gonzalez, J Fontcuberta, F de la Llama
Pageof 18